PD-1 therapy with eribulin for triple negative MBC

Women experiencing menopause symptoms less likely to adhere to medication

Breast cancer mortality declining globally

Everolimus extends PFS for HR positive, HER2 negative breast cancer

TEAM IIb trial results: Adjuvant ibandronate in early breast cancer

Neoadjuvant abemaciclib for HR positive, HER negative breast cancer

TCHP with/out oestrogen for HR/HER positive breast cancer

Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in metastatic breast cancer

Extended adjuvant endrocine therapy with letrozole after aromatase inhibition

Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer

ASH 2016: Multiple myeloma highlights

Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin lymphoma